Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa A Lewis

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Infection and Immunity|November 23, 2011
Enhanced bacteremia in human factor H transgenic rats infected by Neisseria meningitidisDavid M Vu, Jutamas Shaughnessy, Lisa A Lewis, et al.
Pathogens and Disease|May 2, 2017
Gonococcal lipooligosaccharide sialylation: virulence factor and target for novel immunotherapeuticsSanjay Ram, Jutamas Shaughnessy, Rosane B de Oliveira, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 17, 2016
Phase-Variable Heptose I Glycan Extensions Modulate Efficacy of 2C7 Vaccine Antibody Directed against Neisseria gonorrhoeae LipooligosaccharideSrinjoy Chakraborti, Lisa A Lewis, Andrew D Cox, et al.
Infection and Immunity|October 22, 2005
Enhanced factor H binding to sialylated Gonococci is restricted to the sialylated lacto-N-neotetraose lipooligosaccharide species: implications for serum resistance and evidence for a bifunctional lipooligosaccharide sialyltransferase in GonococciSunita Gulati, Andrew Cox, Lisa A Lewis, et al.
Plos Pathogens|October 9, 2025
The gonococcal vaccine candidate antigen NGO1701 is a N. gonorrhoeae periplasmic copper storage proteinShea K Roe, Rafał Mazgaj, Tianmou Zhu, et al.
Infection and Immunity|November 7, 2007
Defining targets for complement components C4b and C3b on the pathogenic neisseriaeLisa A Lewis, Sanjay Ram, Alpana Prasad, et al.
Biorxiv : the Preprint Server for Biology|July 14, 2025
The gonococcal vaccine candidate antigen NGO1701 is a <i>N. gonorrhoeae</i> periplasmic copper storage proteinShea K Roe, Rafał Mazgaj, Tianmou Zhu, et al.
Infection and Immunity|May 29, 2007
Heptose I glycan substitutions on Neisseria gonorrhoeae lipooligosaccharide influence C4b-binding protein binding and serum resistanceSanjay Ram, Jutamas Ngampasutadol, Andrew D Cox, et al.
Infection and Immunity|December 31, 2008
Phosphoethanolamine substitution of lipid A and resistance of Neisseria gonorrhoeae to cationic antimicrobial peptides and complement-mediated killing by normal human serumLisa A Lewis, Biswa Choudhury, Jacqueline T Balthazar, et al.
Mbio|October 31, 2023
Preclinical efficacy of a cell division protein candidate gonococcal vaccine identified by artificial intelligenceSunita Gulati, Andreas Holm Mattsson, Sophie Schussek, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Infection and Immunity|November 23, 2011
Enhanced bacteremia in human factor H transgenic rats infected by Neisseria meningitidisDavid M Vu, Jutamas Shaughnessy, Lisa A Lewis, et al.
Pathogens and Disease|May 2, 2017
Gonococcal lipooligosaccharide sialylation: virulence factor and target for novel immunotherapeuticsSanjay Ram, Jutamas Shaughnessy, Rosane B de Oliveira, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 17, 2016
Phase-Variable Heptose I Glycan Extensions Modulate Efficacy of 2C7 Vaccine Antibody Directed against Neisseria gonorrhoeae LipooligosaccharideSrinjoy Chakraborti, Lisa A Lewis, Andrew D Cox, et al.
Infection and Immunity|October 22, 2005
Enhanced factor H binding to sialylated Gonococci is restricted to the sialylated lacto-N-neotetraose lipooligosaccharide species: implications for serum resistance and evidence for a bifunctional lipooligosaccharide sialyltransferase in GonococciSunita Gulati, Andrew Cox, Lisa A Lewis, et al.
Plos Pathogens|October 9, 2025
The gonococcal vaccine candidate antigen NGO1701 is a N. gonorrhoeae periplasmic copper storage proteinShea K Roe, Rafał Mazgaj, Tianmou Zhu, et al.
Infection and Immunity|November 7, 2007
Defining targets for complement components C4b and C3b on the pathogenic neisseriaeLisa A Lewis, Sanjay Ram, Alpana Prasad, et al.
Biorxiv : the Preprint Server for Biology|July 14, 2025
The gonococcal vaccine candidate antigen NGO1701 is a <i>N. gonorrhoeae</i> periplasmic copper storage proteinShea K Roe, Rafał Mazgaj, Tianmou Zhu, et al.
Infection and Immunity|May 29, 2007
Heptose I glycan substitutions on Neisseria gonorrhoeae lipooligosaccharide influence C4b-binding protein binding and serum resistanceSanjay Ram, Jutamas Ngampasutadol, Andrew D Cox, et al.
Infection and Immunity|December 31, 2008
Phosphoethanolamine substitution of lipid A and resistance of Neisseria gonorrhoeae to cationic antimicrobial peptides and complement-mediated killing by normal human serumLisa A Lewis, Biswa Choudhury, Jacqueline T Balthazar, et al.
Mbio|October 31, 2023
Preclinical efficacy of a cell division protein candidate gonococcal vaccine identified by artificial intelligenceSunita Gulati, Andreas Holm Mattsson, Sophie Schussek, et al.
Pageof 5